Published in Infect Immun on February 01, 2005
CCR5-dependent homing of naturally occurring CD4+ regulatory T cells to sites of Leishmania major infection favors pathogen persistence. J Exp Med (2006) 1.88
Enhanced Leishmania braziliensis infection following pre-exposure to sandfly saliva. PLoS Negl Trop Dis (2007) 1.63
Toward a novel experimental model of infection to study American cutaneous leishmaniasis caused by Leishmania braziliensis. Infect Immun (2005) 1.27
Cytokines, signaling pathways, and effector molecules required for the control of Leishmania (Viannia) braziliensis in mice. Infect Immun (2007) 1.09
Leishmania RNA virus: when the host pays the toll. Front Cell Infect Microbiol (2012) 1.08
Lutzomyia longipalpis saliva or salivary protein LJM19 protects against Leishmania braziliensis and the saliva of its vector, Lutzomyia intermedia. PLoS Negl Trop Dis (2011) 1.08
Immunity to Lutzomyia intermedia saliva modulates the inflammatory environment induced by Leishmania braziliensis. PLoS Negl Trop Dis (2010) 1.02
CXCR1 and SLC11A1 polymorphisms affect susceptibility to cutaneous leishmaniasis in Brazil: a case-control and family-based study. BMC Med Genet (2010) 0.99
Role of Toll-like receptor 9 signaling in experimental Leishmania braziliensis infection. Infect Immun (2013) 0.97
The immunobiology of Leishmania braziliensis infection. Front Immunol (2012) 0.97
Deception and manipulation: the arms of leishmania, a successful parasite. Front Immunol (2014) 0.93
Host genetic factors in American cutaneous leishmaniasis: a critical appraisal of studies conducted in an endemic area of Brazil. Mem Inst Oswaldo Cruz (2014) 0.90
Genetic and functional evaluation of the role of CXCR1 and CXCR2 in susceptibility to visceral leishmaniasis in north-east India. BMC Med Genet (2011) 0.87
PPAR activation induces M1 macrophage polarization via cPLA₂-COX-2 inhibition, activating ROS production against Leishmania mexicana. Biomed Res Int (2013) 0.83
BALB/c mice infected with antimony treatment refractory isolate of Leishmania braziliensis present severe lesions due to IL-4 production. PLoS Negl Trop Dis (2011) 0.83
CCL3L1 copy number and susceptibility to malaria. Infect Genet Evol (2012) 0.83
Ecto-nucleotidase activities of promastigotes from Leishmania (Viannia) braziliensis relates to parasite infectivity and disease clinical outcome. PLoS Negl Trop Dis (2012) 0.81
Synthetic 1,4-pyran naphthoquinones are potent inhibitors of dengue virus replication. PLoS One (2013) 0.79
Chronicity of dermal leishmaniasis caused by Leishmania panamensis is associated with parasite-mediated induction of chemokine gene expression. Infect Immun (2014) 0.79
Distinct cellular migration induced by Leishmania infantum chagasi and saliva from Lutzomyia longipalpis in a hemorrhagic pool model. Rev Inst Med Trop Sao Paulo (2014) 0.75
In situ immunopathological changes in cutaneous leishmaniasis due to Leishmania donovani. Parasite Immunol (2017) 0.75
Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. J Exp Med (1993) 4.49
Human monocyte chemoattractant protein-1 (MCP-1). Immunol Today (1990) 3.31
Expression and biologic characterization of the murine chemokine KC. J Immunol (1995) 2.66
Macrophage inflammatory protein 1 modulates macrophage function. J Immunol (1992) 2.66
MIP-1alpha, MIP-1beta, RANTES, and ATAC/lymphotactin function together with IFN-gamma as type 1 cytokines. Proc Natl Acad Sci U S A (2002) 1.79
Synthesis of the CC-chemokines MIP-1alpha, MIP-1beta, and RANTES is associated with a type 1 immune response. J Immunol (1996) 1.61
Interleukin 10 increases CCR5 expression and HIV infection in human monocytes. J Exp Med (1998) 1.58
Leishmania major: promastigotes induce expression of a subset of chemokine genes in murine macrophages. Exp Parasitol (1997) 1.51
[American cutaneous leishmaniasis]. Rev Soc Bras Med Trop (2003) 1.46
Differential expression of chemokines in patients with localized and diffuse cutaneous American leishmaniasis. J Infect Dis (1996) 1.44
Leishmania-induced cellular recruitment during the early inflammatory response: modulation of proinflammatory mediators. J Infect Dis (2002) 1.42
Expression of cytokines and inducible nitric oxide synthase mRNA in the lungs of mice infected with Cryptococcus neoformans: effects of interleukin-12. Infect Immun (1997) 1.39
Chemokines, natural killer cells and granulocytes in the early course of Leishmania major infection in mice. Med Microbiol Immunol (2001) 1.38
Lymphotactin is produced by NK cells and attracts both NK cells and T cells in vivo. J Immunol (1997) 1.28
Lymphadenopathy as the first sign of human cutaneous infection by Leishmania braziliensis. Am J Trop Med Hyg (1995) 1.24
Regulatory effects of macrophage inflammatory protein 1alpha/CCL3 on the development of immunity to Cryptococcus neoformans depend on expression of early inflammatory cytokines. Infect Immun (2001) 1.22
Early gene expression of NK cell-activating chemokines in mice resistant to Leishmania major. Infect Immun (1999) 1.21
Distinct functions of interferon-gamma for chemokine expression in models of acute lung inflammation. Immunology (1998) 1.14
Serum concentrations of MIP-1 alpha and interleukin-8 in patients suffering from acute Plasmodium falciparum malaria. Clin Immunol Immunopathol (1995) 1.12
Bubonic leishmaniasis: a common manifestation of Leishmania (Viannia) braziliensis infection in Ceara, Brazil. Am J Trop Med Hyg (1995) 1.10
Leishmania braziliensis isolates differing at the genome level display distinctive features in BALB/c mice. Microbes Infect (2004) 1.02
Leishmania major: infection of human monocytes induces expression of IL-8 and MCAF. Exp Parasitol (1996) 0.95
Lymphadenopathy associated with Leishmania braziliensis cutaneous infection. Am J Trop Med Hyg (1992) 0.95
Patterns of chemokine expression in models of Schistosoma mansoni inflammation and infection reveal relationships between type 1 and type 2 responses and chemokines in vivo. Infect Immun (2001) 0.89
Adenoviral-mediated gene transfer of lymphotactin to the lungs of mice and rats results in infiltration and direct accumulation of CD4+, CD8+, and NK cells. J Interferon Cytokine Res (2002) 0.86
Severe Plasmodium vivax malaria exhibits marked inflammatory imbalance. Malar J (2010) 2.88
Assessing patient satisfaction with cataract surgery under topical anesthesia supplemented by intracameral lidocaine combined with sedation. Arq Bras Oftalmol (2014) 2.06
Seroconversion against Lutzomyia longipalpis saliva concurrent with the development of anti-Leishmania chagasi delayed-type hypersensitivity. J Infect Dis (2002) 1.83
CD4+CD25+ T cells in skin lesions of patients with cutaneous leishmaniasis exhibit phenotypic and functional characteristics of natural regulatory T cells. J Infect Dis (2006) 1.77
Enhanced Leishmania braziliensis infection following pre-exposure to sandfly saliva. PLoS Negl Trop Dis (2007) 1.63
Discovery of markers of exposure specific to bites of Lutzomyia longipalpis, the vector of Leishmania infantum chagasi in Latin America. PLoS Negl Trop Dis (2010) 1.60
Neutrophils and macrophages cooperate in host resistance against Leishmania braziliensis infection. J Immunol (2009) 1.41
CD8(+) granzyme B(+)-mediated tissue injury vs. CD4(+)IFNγ(+)-mediated parasite killing in human cutaneous leishmaniasis. J Invest Dermatol (2013) 1.39
Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis. BMC Infect Dis (2005) 1.39
Human anti-saliva immune response following experimental exposure to the visceral leishmaniasis vector, Lutzomyia longipalpis. Eur J Immunol (2007) 1.38
Saliva from Lutzomyia longipalpis induces CC chemokine ligand 2/monocyte chemoattractant protein-1 expression and macrophage recruitment. J Immunol (2005) 1.37
Anti-Anopheles darlingi saliva antibodies as marker of Plasmodium vivax infection and clinical immunity in the Brazilian Amazon. Malar J (2009) 1.30
Toward a novel experimental model of infection to study American cutaneous leishmaniasis caused by Leishmania braziliensis. Infect Immun (2005) 1.27
IFN-beta impairs superoxide-dependent parasite killing in human macrophages: evidence for a deleterious role of SOD1 in cutaneous leishmaniasis. J Immunol (2009) 1.26
Interactions with apoptotic but not with necrotic neutrophils increase parasite burden in human macrophages infected with Leishmania amazonensis. J Leukoc Biol (2008) 1.25
Using recombinant proteins from Lutzomyia longipalpis saliva to estimate human vector exposure in visceral Leishmaniasis endemic areas. PLoS Negl Trop Dis (2010) 1.25
Inflammatory cell infiltration and high antibody production in BALB/c mice caused by natural exposure to Lutzomyia longipalpis bites. Am J Trop Med Hyg (2005) 1.24
Antibodies against Lutzomyia longipalpis saliva in the fox Cerdocyon thous and the sylvatic cycle of Leishmania chagasi. Trans R Soc Trop Med Hyg (2006) 1.22
Polymerase chain reaction (PCR) is highly sensitive for diagnosis of mucosal leishmaniasis. Acta Trop (2005) 1.20
Human mucosal leishmaniasis: neutrophils infiltrate areas of tissue damage that express high levels of Th17-related cytokines. Eur J Immunol (2010) 1.20
Chemokines in host-parasite interactions in leishmaniasis. Trends Parasitol (2005) 1.18
Cooperation between apoptotic and viable metacyclics enhances the pathogenesis of Leishmaniasis. PLoS One (2009) 1.17
Leishmania (L.) amazonensis-induced inhibition of nitric oxide synthesis in host macrophages. Microbes Infect (2002) 1.10
Lung granulomas from Mycobacterium tuberculosis/HIV-1 co-infected patients display decreased in situ TNF production. Pathol Res Pract (2007) 1.09
Clinical utility of polymerase chain reaction-based detection of Leishmania in the diagnosis of American cutaneous leishmaniasis. Clin Infect Dis (2003) 1.09
Lutzomyia longipalpis saliva or salivary protein LJM19 protects against Leishmania braziliensis and the saliva of its vector, Lutzomyia intermedia. PLoS Negl Trop Dis (2011) 1.08
The host genetic diversity in malaria infection. J Trop Med (2012) 1.08
Frequency of infection of Lutzomyia phlebotomines with Leishmania braziliensis in a Brazilian endemic area as assessed by pinpoint capture and polymerase chain reaction. Mem Inst Oswaldo Cruz (2002) 1.06
Leishmania amazonensis infection impairs differentiation and function of human dendritic cells. J Leukoc Biol (2007) 1.05
Association between the haptoglobin and heme oxygenase 1 genetic profiles and soluble CD163 in susceptibility to and severity of human malaria. Infect Immun (2012) 1.04
Vaccination with the Leishmania major ribosomal proteins plus CpG oligodeoxynucleotides induces protection against experimental cutaneous leishmaniasis in mice. Microbes Infect (2008) 1.03
Lutzomyia longipalpis salivary gland homogenate impairs cytokine production and costimulatory molecule expression on human monocytes and dendritic cells. Infect Immun (2004) 1.03
Seasonal patterns of viral and bacterial infections among children hospitalized with community-acquired pneumonia in a tropical region. Scand J Infect Dis (2010) 1.02
Networking the host immune response in Plasmodium vivax malaria. Malar J (2013) 1.02
Leishmania braziliensis isolates differing at the genome level display distinctive features in BALB/c mice. Microbes Infect (2004) 1.02
Haematophagous arthropod saliva and host defense system: a tale of tear and blood. An Acad Bras Cienc (2005) 1.02
Lutzomyia longipalpis saliva triggers lipid body formation and prostaglandin E₂ production in murine macrophages. PLoS Negl Trop Dis (2010) 1.02
Immunity to Lutzomyia intermedia saliva modulates the inflammatory environment induced by Leishmania braziliensis. PLoS Negl Trop Dis (2010) 1.02
Lesion size correlates with Leishmania antigen-stimulated TNF-levels in human cutaneous leishmaniasis. Am J Trop Med Hyg (2011) 1.01
Potential of KM+ lectin in immunization against Leishmania amazonensis infection. Vaccine (2006) 1.00
Hepatitis B infection is associated with asymptomatic malaria in the Brazilian Amazon. PLoS One (2011) 1.00
Metabolic adaptation to tissue iron overload confers tolerance to malaria. Cell Host Microbe (2012) 1.00
Heme impairs prostaglandin E2 and TGF-beta production by human mononuclear cells via Cu/Zn superoxide dismutase: insight into the pathogenesis of severe malaria. J Immunol (2010) 0.99
Glycoinositolphospholipids from Trypanosoma cruzi interfere with macrophages and dendritic cell responses. Infect Immun (2002) 0.98
The role of respiratory viral infections among children hospitalized for community-acquired pneumonia in a developing country. Pediatr Infect Dis J (2008) 0.97
Role of Toll-like receptor 9 signaling in experimental Leishmania braziliensis infection. Infect Immun (2013) 0.97
American cutaneous leishmaniasis unresponsive to antimonial drugs: successful treatment using combination of N-methilglucamine antimoniate plus pentoxifylline. Int J Dermatol (2003) 0.97
Heme oxygenase-1 promotes the persistence of Leishmania chagasi infection. J Immunol (2012) 0.96
The replication of human immunodeficiency virus type 1 in macrophages is enhanced after phagocytosis of apoptotic cells. J Infect Dis (2002) 0.96
Prognostic value of cytokines and chemokines in addition to the GRACE Score in non-ST-elevation acute coronary syndromes. Clin Chim Acta (2010) 0.96
Lutzomyia longipalpis saliva drives apoptosis and enhances parasite burden in neutrophils. J Leukoc Biol (2011) 0.95
CD16+ monocytes in human cutaneous leishmaniasis: increased ex vivo levels and correlation with clinical data. J Leukoc Biol (2005) 0.95
Functional transcriptomics of wild-caught Lutzomyia intermedia salivary glands: identification of a protective salivary protein against Leishmania braziliensis infection. PLoS Negl Trop Dis (2013) 0.95
Plasma superoxide dismutase-1 as a surrogate marker of vivax malaria severity. PLoS Negl Trop Dis (2010) 0.94